NR3C2 and neoplasm: Further RNA-sequencing (RNA-seq) analysis confirmed that subcutaneously grafted CT26.WT tumours responded distinctly at the transcriptomic level to MR in Balb/c and NSG mice (Extended Data Fig. 3c–f and Supplementary Tables 2 and 3), indicating that host immune activity is a key determinant of the tumour response to MR.